Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases

Ageing Research Reviews

Volumn 35, Issue , 2017, Pages 301-311

  Vitiello, Milena ^a   Zullo, Alberto ^b,c   Servillo, Luigi ^a   Mancini, Francesco Paolo ^b   Borriello, Adriana ^a   Giovane, Alfonso ^a   Della Ragione, Fulvio ^a   D'Onofrio, Nunzia ^a   Balestrieri, Maria Luisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Aging; Atherosclerosis; Cancer; Cardiovascular disease; Lifespan; SIRT6

Indexed keywords

SIRTUIN 6; SIRT6 PROTEIN, HUMAN; SIRTUIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DOWN REGULATION; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; LONGEVITY; MALIGNANT NEOPLASM; MYOFIBROBLAST; NONHUMAN; REVIEW; UPREGULATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL; DNA REPAIR; HOMEOSTASIS; METABOLISM; NEOPLASM; PHYSIOLOGY; TELOMERE HOMEOSTASIS;

CARDIOVASCULAR DISEASES; DNA REPAIR; HOMEOSTASIS; HUMANS; LONGEVITY; NEOPLASMS; SIRTUINS; TELOMERE HOMEOSTASIS;

EID: 85006459117     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.10.008     Document Type: Review

References (116)

1. Atsumi, Y., Minakawa, Y., Ono, M., Dobashi, S., Shinohe, K., Shinohara, A., Takeda, S., Takagi, M., Takamatsu, N., Nakagama, H., Teraoka, H., Yoshioka, K., ATM and SIRT6/SNF2H mediate transient H2AX stabilization when DSBs form by blocking HUWE1 to allow efficient gammaH2AX foci formation. Cell Rep. 13 (2015), 2728–2740.
2. Balestrieri, M.L., Fiorito, C., Crimi, E., Felice, F., Schiano, C., Milone, L., Casamassimi, A., Giovane, A., Grimaldi, V., del Giudice, V., Minucci, P.B., Mancini, F.P., Servillo, L., D'Armiento, F.P., Farzati, B., Napoli, C., Effect of red wine antioxidants and minor polyphenolic constituents on endothelial progenitor cells after physical training in mice. Int. J. Cardiol. 126 (2008), 295–297.
3. Balestrieri, M.L., Servillo, L., Esposito, A., D'Onofrio, N., Giovane, A., Casale, R., Barbieri, M., Paolisso, P., Rizzo, M.R., Paolisso, G., Marfella, R., Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation. Diabetologia 56 (2013), 162–172.
4. Balestrieri, M.L., Rizzo, M.R., Barbieri, M., Paolisso, P., D'Onofrio, N., Giovane, A., Siniscalchi, M., Minicucci, F., Sardu, C., D'Andrea, D., Mauro, C., Ferraraccio, F., Servillo, L., Chirico, F., Caiazzo, P., Paolisso, G., Marfella, R., Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Diabetes 64 (2015), 1395–1406.
5. + responses. J. Biol. Chem. 287 (2012), 40924–40937.
6. Bhardwaj, A., Das, S., SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E538–547.
7. Bindu, S., Pillai, V.B., Gupta, M.P., Role of sirtuins in regulating pathophysiology of the heart. Trends Endocrinol. Metab. 27 (2016), 563–573.
8. Bosch-Presegué, L., Vaquero, A., The dual role of sirtuins in cancer. Genes Cancer 2 (2011), 648–662.
9. Cai, Y., Yu, S.S., Chen, S.R., Pi, R.B., Gao, S., Li, H., Ye, J.T., Liu, P.Q., Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. FEBS Lett. 586 (2012), 866–874.
10. Cardus, A., Uryga, A.K., Walters, G., Erusalimsky, J.D., SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc. Res. 97 (2013), 571–579.
11. Cattelan, A., Ceolotto, G., Bova, S., Albiero, M., Kuppusamy, M., De Martin, S., Semplicini, A., Fadini, G.P., de Kreutzenberg, S.V., Avogaro, A., NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. Vascul. Pharmacol. 70 (2015), 35–44.
12. Cea, M., Cagnetta, A., Adamia, S., Acharya, C., Tai, Y.T., Fulciniti, M., Ohguchi, H., Munshi, A., Acharya, P., Bhasin, M.K., Zhong, L., Carrasco, R., Monacelli, F., Ballestrero, A., Richardson, P., Gobbi, M., Lemoli, R.M., Munshi, N., Hideshima, T., Nencioni, A., Chauhan, D., Anderson, K.C., Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells. Blood 127 (2016), 1138–1150.
13. Chen, X., Hao, B., Liu, Y., Dai, D., Han, G., Li, Y., Wu, X., Zhou, X., Yue, Z., Wang, L., Cao, Y., Liu, J., The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma. Biochem. Biophys. Res. Commun. 446 (2014), 364–369.
14. Chen, Y., Sun, T., Wu, J., Kalionis, B., Zhang, C., Yuan, D., Huang, J., Cai, W., Fang, H., Xia, S., Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-kappa B pathway. Biomed. Res. Int., 2015, 2015, 895976.
15. Choe, M., Brusgard, J.L., Chumsri, S., Bhandary, L., Zhao, X.F., Lu, S., Goloubeva, O.G., Polster, B.M., Fiskum, G.M., Girnun, G.D., Kim, M.S., Passaniti, A., The RUNX2 transcription factor negatively regulates SIRT6 expression to alter glucose metabolism in breast cancer cells. J. Cell Biochem. 116 (2015), 2210–2226.
16. Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C.M., Warrier, N.P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J.C., Esplugues, E., Fisher, E.A., Penalva, L.O., Moore, K.J., Suárez, Y., Lai, E.C., Fernández-Hernando, C., miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9232–9237.
17. D'Onofrio, N., Vitiello, M., Casale, R., Servillo, L., Giovane, A., Balestrieri, M.L., Sirtuins in vascular diseases: emerging roles and therapeutic potential. Biochim. Biophys. Acta. 1852 (2015), 1311–1322.
18. D'Onofrio, N., Servillo, L., Giovane, A., Casale, R., Vitiello, M., Marfella, R., Paolisso, G., Balestrieri, M.L., Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6. Free Radic. Biol. Med. 19 (2016), 211–222.
19. De Meyer, G.R., Martinet, W., Autophagy in the cardiovascular system. Biochim. Biophys. Acta 1793 (2009), 1485–1495.
20. De Nigris, F., Balestrieri, M.L., Napoli, C., Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders. Cell Cycle 5 (2006), 1621–1628.
21. Dominy, J.E. Jr., Lee, Y., Jedrychowski, M.P., Chim, H., Jurczak, M.J., Camporez, J.P., Ruan, H.B., Feldman, J., Pierce, K., Mostoslavsky, R., Denu, J.M., Clish, C.B., Yang, X., Shulman, G.I., Gygi, S.P., Puigserver, P., The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell. 48 (2012), 900–913.
22. Elhanati, S., Kanfi, Y., Varvak, A., Roichman, A., Carmel-Gross, I., Barth, S., Gibor, G., Cohen, H.Y., Multiple regulatory layers of SREBP1/2 by SIRT6. Cell Rep. 4 (2013), 905–912.
23. Elhanati, S., Ben-Hamo, R., Kanfi, Y., Varvak, A., Glazz, R., Lerrer, B., Efroni, S., Cohen, H.Y., Reciprocal regulation between SIRT6 and miR-122 controls liver metabolism and predicts hepatocarcinoma prognosis. Cell Rep. 14 (2016), 234–242.
24. Feng, M.Y., Wang, K., Song, H.T., Yu, H.W., Qin, Y., Shi, Q.T., Geng, J.S., Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cells. Clin. Exp. Metastasis. 26 (2009), 1013–1023.
25. 2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence. Cancer Sci. 106 (2015), 559–566.
26. Ferré, P., The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 (2004), 43–50.
27. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., Guarente, L., Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20 (2006), 1075–1080.
28. Frye, R.A., Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000), 793–798.
29. George, J., Ahmad, N., Mitochondrial sirtuins in cancer: emerging roles and therapeutic potential. Cancer Res. 76 (2016), 2500–2506.
30. Gertz, M., Fischer, F., Nguyen, G.T., Lakshminarasimhan, M., Schutkowski, M., Weyand, M., Steegborn, C., Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E2772–E2781.
31. Giblin, W., Skinner, M.E., Lombard, D.B., Sirtuins: guardians of mammalian healthspan. Trends Genet. 30 (2014), 271–286.
32. Han, Z., Liu, L., Liu, Y., Li, S., Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer. Int. J Clin. Exp. Pathol. 7 (2014), 4774–4781.
33. Hariharan, N., Ikeda, Y., Hong, C., Alcendor, R.R., Usui, S., Gao, S., Maejima, Y., Sadoshima, J., Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart. PLoS One, 8, 2013, e51632.
34. Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., Serrano, M., Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun., 1, 2010, 3.
35. Hu, J., He, B., Bhargava, S., Lin, H., A fluorogenic assay for screening Sirt6 modulators. Org. Biomol. Chem. 11 (2013), 5213–5216.
36. Huang, J.Y., Hirschey, M.D., Shimazu, T., Ho, L., Verdin, E., Mitochondrial sirtuins. Biochim. Biophys. Acta 1804 (2010), 1645–1651.
37. Ignarro, L.J., Balestrieri, M.L., Napoli, C., 2007 Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 73 (2007), 326–340.
38. Jiang, H., Khan, S., Wang, Y., Charron, G., He, B., Sebastian, C., Du, J., Kim, R., Ge, E., Mostoslavsky, R., Hang, H.C., Hao, Q., Lin, H., SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496 (2013), 110–113.
39. Kaidi, A., Weinert, B.T., Choudhary, C., Jackson, S.P., Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329 (2010), 1348–1353.
40. Kanfi, Y., Peshti, V., Gil, R., Naiman, S., Nahum, L., Levin, E., Kronfeld-Schor, N., Cohen, H.Y., SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell. 9 (2010), 162–173.
41. Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., Bar-Joseph, Z., Cohen, H.Y., The sirtuin SIRT6 regulates lifespan in male mice. Nature 483 (2012), 218–221.
42. Kawahara, T.L., Michishita, E., Adler, A.S., Damian, M., Berber, E., Lin, M., McCord, R.A., Ongaigui, K.C., Boxer, L.D., Chang, H.Y., Chua, K.F., SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136 (2009), 62–74.
43. Kim, E.J., Juhnn, Y.S., Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway. J. Biol. Chem. 290 (2015), 9604–9613.
44. Kim, H.S., Xiao, C., Wang, R.H., Lahusen, T., Xu, X., Vassilopoulos, A., Vazquez-Ortiz, G., Jeong, W.I., Park, O., Ki, S.H., Gao, B., Deng, C.X., Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell. Metab. 12 (2010), 224–236.
45. Kimura, Y., Izumiya, Y., Araki, S., Yamamura, S., Onoue, Y., Hanatani, S., Ogawa, H., SIRT7 deficiency in blood vessel components impairs vascular function by inhibiting cell cycle and inflammatory-related protein expression. Circulation, 132, 2015, A14820.
46. Kleszcz, R., Paluszczak, J., Baer-Dubowska, W., Targeting aberrant cancer metabolism − the role of sirtuins. Pharmacol. Rep. 67 (2015), 1068–1080.
47. Kokkonen, P., Rahnasto-Rilla, M., Mellini, P., Jarho, E., Lahtela-Kakkonen, M., Kokkola, T., Studying SIRT6 regulation using H3K56 based substrate and small molecules. Eur. J. Pharm. Sci. 63 (2014), 71–76.
48. Koltai, E., Szabo, Z., Atalay, M., Boldogh, I., Naito, H., Goto, S., Nyakas, C., Radak, Z., Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech. Ageing Dev. 131 (2010), 21–28.
49. Kugel, S., Feldman, J.L., Klein, M.A., Silberman, D.M., Sebastián, C., Mermel, C., Dobersch, S., Clark, A.R., Getz, G., Denu, J.M., Mostoslavsky, R., Identification of and molecular basis for SIRT6 loss-of-function point mutations in cancer. Cell Rep. 13 (2015), 479–488.
50. Kugel, S., Sebastián, C., Fitamant, J., Ross, K.N., Saha, S.K., Jain, E., Gladden, A., Arora, K.S., Kato, Y., Rivera, M.N., Ramaswamy, S., Sadreyev, R.I., Goren, A., Deshpande, V., Bardeesy, N., Mostoslavsky, R., SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell 165 (2016), 1401–1415.
51. Lai, C.C., Lin, P.M., Lin, S.F., Hsu, C.H., Lin, H.C., Hu, M.L., Hsu, C.M., Yang, M.Y., Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol. 34 (2013), 1847–1854.
52. Lappas, M., Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediators Inflamm., 2012, 2012, 597514.
53. Lefort, K., Brooks, Y., Ostano, P., Cario-André, M., Calpini, V., Guinea-Viniegra, J., Albinger-Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E.F., Werner, S., Dotto, G.P., A miR-34a-SIRT6 axis in the squamous cell differentiation network. EMBO J. 32 (2013), 2248–2263.
54. Lerrer, B., Gertler, A.A., Cohen, H.Y., The complex role of SIRT6 in carcinogenesis. Carcinogenesis 37 (2016), 108–118.
55. Lin, Z., Yang, H., Tan, C., Li, J., Liu, Z., Quan, Q., Kong, S., Ye, J., Gao, B., Fang, D., USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell. Rep. 5 (2013), 1639–1649.
56. Liszt, G., Ford, E., Kurtev, M., Guarente, L., Mouse sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280 (2005), 21313–21320.
57. Liu, M., Li, Z., Chen, G.W., Li, Z.M., Wang, L.P., Ye, J.T., Luo, H.B., Liu, P.Q., AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy. Mol. Cell. Endocrinol. 392 (2014), 14–22.
58. Liu, R., Liu, H., Ha, Y., Tilton, R.G., Zhang, W., Oxidative stress induces endothelial cell senescence via downregulation of Sirt6. Biomed. Res. Int., 2014, 2014 902842.
59. Liu, Z., Wang, J., Huang, X., Li, Z., Liu, P., Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice. Transl. Res. 172 (2016), 18–29.
60. Lu, C.T., Hsu, C.M., Lin, P.M., Lai, C.C., Lin, H.C., Yang, C.H., Hsiao, H.H., Liu, Y.C., Lin, H.Y., Lin, S.F., Yang, M.Y., The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma. Anticancer Res. 34 (2014), 7137–7143.
61. Lu, J., Sun, D., Liu, Z., Li, M., Hong, H., Liu, C., Gao, S., Li, H., Cai, Y., Chen, S., Li, Z., Ye, J., Liu, P., SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy. Transl. Res. 172 (2016), 96–112.
62. Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., Gorbunova, V., SIRT6 promotes DNA repair under stress by activating PARP1. Science 332 (2011), 1443–1446.
63. Masri, S., Sirtuin-dependent clock control: new advances in metabolism, aging and cancer. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 521–527.
64. McCord, R.A., Michishita, E., Hong, T., Berber, E., Boxer, L.D., Kusumoto, R., Guan, S., Shi, X., Gozani, O., Burlingame, A.L., Bohr, V.A., Chua, K.F., SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY). 1 (2009), 109–121.
65. Michishita, E., McCord, R.A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T.L., Barrett, J.C., Chang, H.Y., Bohr, V.A., Ried, T., Gozani, O., Chua, K.F., SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452 (2008), 492–496.
66. Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., Zatloukal, K., Hui, L., Wagner, E.F., Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 14 (2012), 1203–1211.
67. Ming, M., Han, W., Zhao, B., Sundaresan, N.R., Deng, C.X., Gupta, M.P., He, Y.Y., SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer. Cancer Res. 74 (2014), 5925–5933.
68. Morris, B.J., Seven sirtuins for seven deadly diseases of aging. Free Radic. Biol. Med. 56 (2013), 133–171.
69. Mostoslavsky, R., Chua, K.F., Lombard, D.B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., Mills, K.D., Patel, P., Hsu, J.T., Hong, A.L., Ford, E., Cheng, H.L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M.O., Hursting, S., Barrett, J.C., Guarente, L., Mulligan, R., Demple, B., Yancopoulos, G.D., Alt, F.W., Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124 (2006), 315–329.
70. Orellana, M.E., Quezada, C., Maloney, S.C., Antecka, E., Balazsi, M., Burnier, M.N. Jr., Expression of SIRT2 and SIRT6 in retinoblastoma. Ophthalmic Res. 53 (2015), 100–108.
71. Pan, P.W., Feldman, J.L., Devries, M.K., Dong, A., Edwards, A.M., Denu, J.M., Structure and biochemical functions of SIRT6. J. Biol. Chem. 286 (2011), 14575–14587.
72. Pan, H., Guan, D., Liu, X., Li, J., Wang, L., Wu, J., Zhou, J., Zhang, W., Ren, R., Zhang, W., Li, Y., Yang, J., Hao, Y., Yuan, T., Yuan, G., Wang, H., Ju, Z., Mao, Z., Li, J., Qu, J., Tang, F., Liu, G.H., SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res. 26 (2016), 190–205.
73. Parenti, M.D., Grozio, A., Bauer, I., Galeno, L., Damonte, P., Millo, E., Sociali, G., Franceschi, C., Ballestrero, A., Bruzzone, S., Del Rio, A., Nencioni, A., Discovery of novel and selective SIRT6 inhibitors. J. Med. Chem. 57 (2014), 4796–4804.
74. Rahnasto-Rilla, M., Kokkola, T., Jarho, E., Lahtela-Kakkonen, M., Moaddel, R., N-Acylethanolamines bind to SIRT6. Chembiochem 17 (2016), 77–81.
75. Ran, L.K., Chen, Y., Zhang, Z.Z., Tao, N.N., Ren, J.H., Zhou, L., Tang, H., Chen, X., Chen, K., Li, W.Y., Huang, A.L., Chen, J., SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway. Clin. Cancer Res. 22 (2016), 3372–3382.
76. Ronnebaum, S.M., Wu, Y., McDonough, H., Patterson, C., The ubiquitin ligase CHIP prevents Sirt6 degradation through non canonical ubiquitination. Mol. Cell. Biol. 33 (2013), 4461–4472.
77. Saraiva, F.K., Sposito, A.C., Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists. Cardiovasc. Diabetol., 13, 2014, 142.
78. Sebastián, C., Zwaans, B.M., Silberman, D.M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A.R., Toiber, D., Cosentino, C., Greenson, J.K., MacDonald, A.I., McGlynn, L., Maxwell, F., Edwards, J., Giacosa, S., Guccione, E., Weissleder, R., Bernstein, B.E., Regev, A., Shiels, P.G., Lombard, D.B., Mostoslavsky, R., The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151 (2012), 1185–1199.
79. Servillo, L., Castaldo, D., Casale, R., D'Onofrio, N., Giovane, A., Cautela, D., Balestrieri, M.L., An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine. Free Radic. Biol. Med. 79 (2015), 228–236.
80. Sharma, A., Diecke, S., Zhang, W.Y., Lan, F., He, C., Mordwinkin, N.M., Chua, K.F., Wu, J.C., The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J. Biol. Chem. 288 (2013), 18439–18447.
81. Singh, N., Ravichandran, S., Norton, D.D., Fugmann, S.D., Moaddel, R., Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography. Anal. Biochem. 436 (2013), 78–83.
82. Sociali, G., Galeno, L., Parenti, M.D., Grozio, A., Bauer, I., Passalacqua, M., Boero, S., Donadini, A., Millo, E., Bellotti, M., Sturla, L., Damonte, P., Puddu, A., Ferroni, C., Varch, G., Franceschi, C., Ballestrero, A., Poggi, A., Bruzzone, S., Nencioni, A., Del Rio, A., Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics. Eur. J. Med. Chem. 102 (2015), 530–539.
83. Sundaresan, N.R., Vasudevan, P., Zhong, L., Kim, G., Samant, S., Parekh, V., Pillai, V.B., Ravindra, P.V., Gupta, M., Jeevanandam, V., Cunningham, J.M., Deng, C.X., Lombard, D.B., Mostoslavsky, R., Gupta, M.P., The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med. 18 (2012), 1643–1650.
84. Tang, Y.L., Zhou, Y., Wang, Y.P., Wang, J.W., Ding, J.C., SIRT6/NF-(B signaling axis in ginsenoside Rg1-delayed hematopoietic stem/progenitor cell senescence. Int. J. Clin. Exp. Pathol. 8 (2015), 5591–5596.
85. +-dependent histone deacetylase SIRT1. J. Biol. Chem. 282 (2007), 6823–6832.
86. Tao, R., Xiong, X., Depinho, R.A., Deng, C.X., Dong, X.C., Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. J. Lipid. Res. 54 (2013), 2745–2753.
87. Tasselli, L., Xi, Y., Zheng, W., Tennen, R.I., Odrowaz, Z., Simeoni, F., Li, W., Chua, K.F., SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence. Nat. Struct. Mol. Biol. 23 (2016), 434–440.
88. TenNapel, M.J., Lynch, C.F., Burns, T.L., Wallace, R., Smith, B.J., Button, A., Domann, F.E., SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohort. PLoS One, 9, 2014, e115616.
89. Tian, K., Liu, Z., Wang, J., Xu, S., You, T., Liu, P., Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling. Transl. Res. 165 (2015), 374–386.
90. Toiber, D., Erdel, F., Bouazoune, K., Silberman, D.M., Zhong, L., Mulligan, P., Sebastian, C., Cosentino, C., Martinez-Pastor, B., Giacosa, S., D'Urso, A., Näär, A.M., Kingston, R., Rippe, K., Mostoslavsky, R., SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol. Cell. 51 (2013), 454–468.
91. Van Meter, M., Kashyap, M., Rezazadeh, S., Geneva, A.J., Morello, T.D., Seluanov, A., Gorbunova, V., SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat. Commun., 5, 2014, 5011.
92. Vaquero, A., Scher, M.B., Lee, D.H., Sutton, A., Cheng, H.L., Alt, F.W., Serrano, L., Sternglanz, R., Reinberg, D., SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20 (2006), 1256–1261.
93. Vazquez, B.N., Thackray, J.K., Simonet, N.G., Kane-Goldsmith, N., Martinez-Redondo, P., Nguyen, T., Bunting, S., Vaquero, A., Tischfield, J.A., Serrano, L., SIRT7 promotes genome integrity and modulates non-homologous end joining DNA repair. EMBO J. 35 (2016), 1488–1503.
94. Wang, X.X., Wang, X.L., Tong, M.M., Gan, L., Chen, H., Wu, S.S., Chen, J.X., Li, R.L., Wu, Y., Zhang, H.Y., Zhu, Y., Li, Y.X., He, J.H., Wang, M., Jiang, W., SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3(-dependent antioxidant defense mechanisms. Basic Res. Cardiol., 2016, 111–113.
95. Warburg, O., Wind, F., Negelein, E., The metabolism of tumors in the body. J. Gen. Physiol. 8 (1927), 519–530.
96. Wu, M., Dickinson, S.I., Wang, X., Zhang, J., Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder. Int. J. Clin. Exp. Pathol. 7 (2014), 6504–6513.
97. Wu, M., Seto, E., Zhang, J., E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells. Oncotarget 6 (2015), 11252–11263.
98. Xiong, X., Wang, G., Tao, R., Wu, P., Kono, T., Li, K., Ding, W.X., Tong, X., Tersey, S.A., Harris, R.A., Mirmira, R.G., Evans-Molina, C., Dong, X.C., Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells. Diabetologia 59 (2016), 151–160.
99. Xu, Z., Zhang, L., Zhang, W., Meng, D., Zhang, H., Jiang, Y., Xu, X., Van Meter, M., Seluanov, A., Gorbunova, V., Mao, Z., SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner. Cell Cycle 14 (2015), 269–276.
100. Xu, S., Yin, M., Koroleva, M., Mastrangelo, M.A., Zhang, W., Bai, P., Little, P.J., Jin, Z.G., SIRT6 protects against endothelial dysfunction and atherosclerosis in mice. Aging (Albany NY). 8 (2016), 1064–1082.
101. Xu, S., Bai, P., Jin, Z.G., Sirtuins in cardiovascular health and diseases. Trends Endocrinol. Metab. 27 (2016), 677–678.
102. Yang, J., Mani, S.A., Donahe, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A., Weinberg, R.A., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004), 927–939.
103. Yang, B., Zwaans, B.M., Eckersdorff, M., Lombard, D.B., The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 8 (2009), 2662–2663.
104. Yang, S.J., Choi, J.M., Chae, S.W., Kim, W.J., Park, S.E., Rhee, E.J., Lee, W.Y., Oh, K.W., Park, S.W., Kim, S.W., Park, C.Y., Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One, 6, 2011, e17057.
105. Yao, Q.P., Zhang, P., Qi, Y.X., Chen, S.G., Shen, B.R., Han, Y., Yan, Z.Q., Jiang, Z.L., The role of SIRT6 in the differentiation of vascular smooth muscle cells in response to cyclic strain. Int. J. Biochem. Cell. Biol. 49 (2014), 98–104.
106. Yasuda, M., Wilson, D.R., Fugmann, S.D., Moaddel, R., Synthesis and characterization of SIRT6 protein coated magnetic beads: identification of a novel inhibitor of SIRT6 deacetylase from medicinal plant extracts. Anal. Chem. 83 (2011), 7400–7407.
107. Ye, X., Li, M., Hou, T., Gao, T., Zhu, W.G., Yang, Y., Sirtuins in glucose and lipid metabolism. Oncotarget, 21, 2016, 10.18632/oncotarget.12157.
108. Yu, S.S., Cai, Y., Ye, J.T., Pi, R.B., Chen, S.R., Liu, P.Q., Shen, X.Y., Ji, Y., Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-(B-dependent transcriptional activity. Br. J. Pharmacol. 168 (2013), 117–128.
109. Zhang, J., Fang, L., Lu, Z., Xiong, J., Wu, M., Shi, L., Luo, A., Wang, S., Are sirtuins markers of ovarian aging?. Gene 575 (2016), 680–686.
110. Zhang, N., Li, Z., Mu, W., Li, L., Liang, Y., Lu, M., Wang, Z., Qiu, Y., Wang, Z., Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling. Cell Cycle 15 (2016), 1009–1018.
111. Zhang, X., Li, W., Shen, P., Feng, X., Yue, Z., Lu, J., You, J., Li, J., Gao, H., Fang, S., Li, Z., Liu, P., STAT3 suppression is involved in the protective effect of SIRT6 against cardiomyocyte hypertrophy. J. Cardiovasc. Pharmacol. 68 (2016), 204–214.
112. Zhang, Z.Q., Ren, S.C., Tan, Y., Li, Z.Z., Tang, X., Wang, T.T., Hao, D.L., Zhao, X., Chen, H.Z., Liu, D.P., Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice. Sci. Rep., 6, 2016, 23912.
113. Zhang, Z.G., Qin, C.Y., Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal-regulated kinase signaling pathway. Mol. Med. Rep. 9 (2014), 882–888.
114. Zhang, P., Tu, B., Wang, H., Cao, Z., Tang, M., Zhang, C., Gu, B., Li, Z., Wang, L., Yang, Y., Zhao, Y., Wang, H., Luo, J., Deng, C.X., Gao, B., Roeder, R.G., Zhu, W.G., Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 10684–10689.
115. Zhang, J., Yin, X.J., Xu, C.J., Ning, Y.X., Chen, M., Zhang, H., Chen, S.F., Yao, L.Q., The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression. Eur. Rev. Med. Pharmacol. Sci. 19 (2015), 818–824.
116. Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R.E., Vadysirisack, D.D., Guimaraes, A., Marinelli, B., Wikstrom, J.D., Nir, T., Clish, C.B., Vaitheesvaran, B., Iliopoulos, O., Kurland, I., Dor, Y., Weissleder, R., Shirihai, O.S., Ellisen, L.W., Espinosa, J.M., Mostoslavsky, R., The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1 alpha. Cell 140 (2010), 280–293.